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MicroRNA (miRNA)-deficient helper T cells exhibit
abnormal IFN-g production and decreased pro-
liferation. However, the contributions of individual
miRNAs to this phenotype remain poorly under-
stood. We conducted a screen for miRNA function
in primary T cells and identified individual miRNAs
that rescue the defects associated with miRNA defi-
ciency. Multiple members of the miR-17 and miR-92
families enhanced miRNA-deficient T cell prolifera-
tion whereas miR-29 largely corrected their aberrant
interferon-g (IFN-g) expression. Repression of IFN-g
production by miR-29 involved direct targeting of
both T-bet and Eomes, two transcription factors
known to induce IFN-g production. Although not
usually expressed at functionally relevant amounts
in helper T cells, Eomes was abundant in miRNA-
deficient cells andwas upregulated aftermiR-29 inhi-
bition in wild-type cells. These results demonstrate
that miR-29 regulates helper T cell differentiation by
repressing multiple target genes, including at least
two that are independently capable of inducing the
T helper 1 (Th1) cell gene expression program.
INTRODUCTION
CD4+ helper T cells play a critical role in the coordination of
effective immune responses. Upon activation, naive CD4+
T cells proliferate and differentiate into effector subsets defined
primarily by distinct cytokine expression (Ansel et al., 2006;
Szabo et al., 2003; Zhu et al., 2010). Because these cytokines
act on many different cell types, the production and regulation
of lineage-specific cytokines is fundamental to generating the
appropriate immune response for different types of immune
challenges. Thus, proper regulation of helper T cell proliferation
and differentiation is critical for effective immune protection from
pathogens. However, dysregulated T cell responses can result
in immunopathology. For example, T helper 1 (Th1) cells secrete
interferon-g (IFN-g) and mediate elimination of intracellularpathogens, but these cells can also contribute to pathologic
inflammation and autoimmune disease. Examining the mecha-
nisms of gene regulation that underlie T cell polarization has
the potential to improve our understanding of cell differentiation
in general and to provide insights for the development of
clinically relevant immune therapies.
The differentiation fate of CD4+ T cells involves integration of
antigen, costimulatory, and cytokine signals that influence the
expression and duration of lineage-specific transcription factors.
Enforced expression of the T-box transcription factor T-bet
dominantly induces IFN-g production, and T-bet-deficient
CD4+ T cells are severely defective in Th1 cell differentiation
and IFN-g production (Szabo et al., 2000). Eomesodermin
(Eomes), a closely related T-box family transcription factor, has
also been shown to regulate IFN-g production, particularly in
CD8+ T cells (Pearce et al., 2003). Although it is normally ex-
pressed at relatively low amounts in CD4+ T cells, Eomes can
substitute for T-bet to induce IFN-g production and Th1 cell
differentiation when its expression is enforced. Once expressed,
IFN-g initiates a positive feedback loop that reinforces its own
production and T-bet expression in helper T cells.
Recent work has identified endogenously expressed micro-
RNAs (miRNAs) as important contributors to the regulation of
helper T cell proliferation, survival, differentiation, and cytokine
production (O’Connell et al., 2010). miRNAs are 22 nucleotide
noncoding RNAs that mediate sequence-dependent posttran-
scriptional negative regulation of gene expression (Bartel,
2009). Primary miRNA transcripts are processed by the micro-
processor complex, consisting of the RNase III enzyme Drosha
and the double-stranded RNA-binding cofactor DGCR8. The
resulting 60 to 80 nucleotide hairpin precursor-miRNAs are
subsequently cleaved by the RNase III enzyme Dicer to form
22 base pair dsRNA duplexes. One strand of this duplex forms
the mature miRNA, which targets mRNAs for repression by
complementary base pairing, especially within the ‘‘miRNA
seed’’ sequence at nucleotide positions 2–8. Genetic inactiva-
tion of either Dicer or Drosha results in considerable functional
defects in CD4+ T cells (Chong et al., 2008; Cobb et al., 2006;
Liston et al., 2008; Muljo et al., 2005; Zhou et al., 2008). Dicer-
deficient cells exhibit a marked bias toward IFN-g production
as well as reduced proliferation and survival after stimulation
in vitro. Similar phenotypes were observed in Drosha-deficient
T cells (Chong et al., 2008). Although both Dicer and DroshaImmunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc. 169
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D E
B Figure 1. Decreased Proliferation and In-
creased IFN-g Production by DGCR8-Defi-
cient CD4+ T Cells
(A) qPCR analysis of miRNA expression in
flow cytometer-sorted YFP+CD4+ T cells cultured
in vitro for 5 days. Bars represent miRNA expres-
sion relative to sno202; error bars represent range
for replicate qPCR reactions.
(B) Proliferation of RFP+CD4+ T cells labeled with
CFSE and analyzed by flow cytometry at the
indicated times in culture. Cells are from Dgcr8fl/fl
Cd4-cre R26-tdRFP mice (gray lines) or Dgcr8+/fl
Cd4-cre R26-tdRFP mice (black lines).
(C–E) Cytokine production by restimulated YFP+
CD4+ T cells cultured in nonpolarizing (ThN) or Th2
cell-type conditions (C); CD4+ T cells cultured in
Th1 cell-type conditions (D); and Dgcr8fl/fl Cd4-cre
YFP+CD4+Tcells cultured±5mg/mLanti-IFN-g (E).
Data are representative of at least three indepen-
dent experiments.
Immunity
miR-29 Regulates Th1 Cell Differentiationhave been implicated in functions outside of miRNA biogenesis,
the overlapping phenotypes of Drosha- and Dicer-deficient
T cells indicate specific involvement of the miRNA pathway.
These studies demonstrate the significance of miRNAs in regu-
lating helper T cell gene expression, but the individual miRNAs
responsible and their mechanisms of function remain largely
undefined.
By using T cells deficient for DGCR8, we established a system
for analyzing the function of individual miRNAs in otherwise
miRNA-deficient cells. Side-by-side comparisons showed that
Dicer- and DGCR8-deficient helper T cells exhibit identical
defects in cytokine regulation and proliferation. We further
demonstrated that these phenotypes result from cell-intrinsic
defects and that reintroduction of DGCR8 after stimulation can
partially rescue the functional defects of these cells. Building
on these findings, we carried out a functional screen and identi-
fied individual miRNAs that can alleviate the defects of miRNA-
deficient cells.170 Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc.RESULTS
DGCR8-Deficient Helper T Cells
To establish a system for studying the
functional effects of miRNAs in helper
T cells, we intercrossed Dgcr8fl/fl mice
(Wang et al., 2007) with Cd4-cre mice.
Dgcr8fl/fl Cd4-cre mice were further
crossed to Gt(ROSA)26Sortm1(EYFP)Cos
(R26-YFP) or Gt(ROSA)26Sortm1Hjf (R26-
tdRFP) mice (Luche et al., 2007) to intro-
duce a fluorescent reporter of Cre ex-
pression. To confirm Dgcr8 inactivation,
we measured miRNA expression in the
YFP+ population in cultured CD4+ T cells
from Dgcr8fl/fl Cd4-cre R26-YFP mice.
DGCR8-dependent miRNA expression
in the Dgcr8fl/fl Cd4-cre YFP+ cells was
below the limit of detection, whereas
control cells expressed all miRNAs ana-lyzed (Figure 1A). miR-320 and miR-484 were still detected in
Dgcr8fl/fl Cd4-cre YFP+ cells, confirming the DGCR8-indepen-
dent expression of these two unusual miRNAs (Babiarz et al.,
2008).
Analysis of lymph nodes and spleen revealed a decrease in the
relative frequency of CD4+ and CD8+ T cells by 50% and
66%, respectively, in Dgcr8fl/fl Cd4-cre mice (see Figure S1A
available online). This reduction is consistent with that reported
for Cd4-cre-mediated deletion of Dicer or Drosha (Chong et al.,
2008; Muljo et al., 2005). We observed no difference in the
frequency of naive (CD62LhiCD44lo) cells among the CD4+
T cells in the lymph nodes and spleen of 4- to 7-week-old
Dgcr8fl/fl Cd4-cre mice (Figure S1B). This is probably due to
the relatively young age of the mice used in this study because
oldermicewith T cell-specific deletion ofmiRNAs do accumulate
previously activated helper T cells (Chong et al., 2008; Cobb
et al., 2006; and data not shown). Moreover, counterselection
against DGCR8-deficient T cells was not apparent in these
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Figure 2. DGCR8-Deficient T Cells Exhibit
Cell-Intrinsic Defects in Cytokine Produc-
tion and IFN-g Signaling
(A) Cytokine production of YFP+ or RFP+CD4+
T cells from Dgcr8fl/fl Cd4-cre R26-tdRFP and
Dgcr8+/fl Cd4-cre R26-YFP mice. YFP and RFP
(left) were used to distinguish Dgcr8+/fl and
Dgcr8fl/fl cells, respectively (right). Cells were
mixed in a 4:1 ratio (Dgcr8fl/fl:Dgcr8+/fl) and co-
cultured in 10 units/mL IL-4. Data are represen-
tative of three independent experiments.
(B) Intracellular protein expression of cocultured
Dgcr8fl/fl Cd4-cre R26-tdRFP (Dgcr8fl/fl) and
Dgcr8+/fl Cd4-cre R26-YFP (Dgcr8+/fl) cells after
68 hr of stimulation (anti-CD3 and anti-CD28).
(C) IFNGR1 and T-bet expression in freshly iso-
lated CD4+ T cells.
(D) Phosphorylated STAT1 expression in freshly
isolated CD4+ T cells ± 10 ng/mL IFN-g for 15 min
in coculture. Shaded histograms represent cells
not treated with IFN-g; Dgcr8+/fl Cd4-cre YFP+
(black) or Dgcr8fl/fl Cd4-cre RFP+ (gray).
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miR-29 Regulates Th1 Cell Differentiationmice; no difference in the frequency of YFP+ cells among CD4+
T cells was observed between Dgcr8fl/fl Cd4-cre mice and
Dgcr8+/fl Cd4-cre littermate controls (Figure S1C).
Like Dicer- and Drosha-deficient helper T cells, DGCR8-
deficient T cells exhibited decreased proliferation (Figure 1B)
and an overwhelming bias toward IFN-g production in vitro
(Figure 1C). The cytokine expression defect of DGCR8- and
Dicer-deficient T cells was essentially identical, indicating that
their common products, namely miRNAs, regulate helper T cell
differentiation. Also consistent with previous reports (Chong
et al., 2008; Muljo et al., 2005), cytokine production by wild-
type and DGCR8-deficient cells was similar in Th1 cell-type
conditions and aberrant IFN-g production was inhibited by Th2
cell-type culture conditions (Figures 1C and 1D). Further, IFN-g
blocking antibody alone was sufficient to mediate this effect
without the addition of interleukin-4 (IL-4) (Figure 1E). This result
demonstrates that aberrant IFN-g production inmiRNA-deficient
cells is dependent on IFN-g signaling and specifically implicates
genes in this pathway as potential targets of miRNA regulation.
Cell-Intrinsic Dysregulation of Cytokine Production
in miRNA-Deficient Cells
Because IFN-g induces a positive feedback loop through
STAT1 and T-bet to reinforce its own expression (Afkarian
et al., 2002; Lighvani et al., 2001), we tested the possibility that
an increase in early IFN-g release could be the proximal cause
of the IFN-g production bias observed in DGCR8-deficient
T cell cultures. Dgcr8fl/fl Cd4-cre R26-tdRFP cells were cocul-Immunity 35, 169–181tured with Dgcr8+/fl Cd4-cre R26-YFP
control cells. This system allowed us to
distinguish the miRNA-deficient RFP+
cells from the control YFP+ cells at the
time of analysis (Figure 2A). DGCR8-
deficient T cells retained their IFN-g
production bias in coculture. However,
despite exposure to the same cytokine
environment as the miRNA-deficientcells, control cells did not exhibit increased IFN-g production.
To better understand this cell-intrinsic difference in cytokine
production, we analyzed additional aspects of the IFN-g feed-
back loop. Activated DGCR8-deficient cells exhibited higher
amounts of both phosphorylated STAT1 (pSTAT1) and T-bet
relative to cocultured control cells (Figure 2B). There is evidence
that the gene encoding the IFN-gRa subunit (Ifngr1) can be
regulated by at least one miRNA (Banerjee et al., 2010), but we
did not observe increased surface expression of this receptor
on unstimulated miRNA-deficient cells (Figure 2C). Additionally,
naive wild-type and miRNA-deficient cells had the same basal
expression of T-bet (Figure 2C) and negligible amounts of
pSTAT1 (Figure 2D, shaded histograms). Notably however, after
treatment with recombinant IFN-g, naive DGCR8-deficient
T cells exhibited more STAT1 phosphorylation than control cells
(Figure 2D, open histograms). We conclude that cell-intrinsic
defects sensitize the IFN-g signaling pathway inmiRNA-deficient
T cells, thus leading to aberrant Th1 cell differentiation and IFN-g
production.
To further examine the requirements for themiRNA pathway in
the cell-intrinsic control of IFN-g production, we used retroviral
transduction to re-express DGCR8 in differentiating DGCR8-
deficient T cells. Those cells that were successfully transduced
with theDgcr8-containing retrovirus exhibited improved prolifer-
ation and a decrease in the frequency of IFN-g-producing cells
(Figure S2A and data not shown). However, untransduced cells
in the same culture remained biased toward IFN-g production.
Cytokine production by miRNA-deficient T cells was also not, August 26, 2011 ª2011 Elsevier Inc. 171
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Figure 3. A Screen for miRNA Function
in DGCR8-Deficient CD4+ T Cells Reveals
Proliferation Rescue by miR-17 and miR-92
Family miRNAs
(A) miRNA expression from deep sequencing
analysis of small RNAs in wild-type CD4+ T cells
stimulated in vitro for 44 hr. Shaded region marks
miRNAs selected for screening. Unshaded region
represents all miRNAs sequenced at least once.
Bars are average frequency of eachmiRNA among
all genome-matching small RNA sequences from
two independent small RNA libraries.
(B) Schematic of workflow for miRNA functional
screen in DGCR8-deficient CD4+ T cells (from
Dgcr8fl/fl Cd4-cre R26-tdRFP mice).
(C) Proliferation index for each miRNA was deter-
mined (see Experimental Procedures) and used to
calculate proliferation Z scores (Z = x-mean/SD
where x represents the normalized proliferation
index for each individual miRNA). All miRNAs in the
miR-17 and miR-92 seed families that were
screened are highlighted.
(D) miR-17 and miR-92 seed family miRNAs
(ordered from highest to lowest Z score).
(E) Proliferation of CFSE-labeled, RFP+ cells 65 hr
posttransfection with individual miR-1792
cluster miRNAs or control miRNA (representative
histograms in left panel). Proliferation index
data were normalized to cells transfected with
control miRNA. Values are means ± SD from five
independent transfections in three independent
experiments; **p < 0.01; ANOVA Tukey’s post-hoc
test.
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miR-29 Regulates Th1 Cell Differentiationaffected by a control retrovirus containing only the Thy1.1marker
gene (Figure S2A). DGCR8 expression led to the expected re-
expression of mature miRNAs (Figure S2B). Taken together,
these results indicate thatmiRNAs dynamically regulate cytokine
production in helper T cells in a cell-autonomousmanner and that
miRNA activity has functional effects on IFN-g production even
after initial activation and polarization events have occurred.
A Screen for Individual miRNA Functions in CD4+ T Cells
After observing the effect of reintroducing DGCR8, we reasoned
that some subset of the miRNAs expressed in T cells must be
responsible for the phenotypic rescue. In order to identify the
miRNAs involved, we implemented a system to screen for indi-
vidual miRNA functions in differentiating CD4+ T cells. Because
of the often cooperative and redundant nature of miRNA func-
tion, there are inherent difficulties in studying individual miRNAs.
To overcome someof these difficulties, we utilizedDgcr8fl/flCd4-
cre mice to allow introduction of individual miRNAs into other-
wise miRNA-deficient helper T cells, an approach that proved
to be a useful and sensitive means for identifying the function
of individual miRNAs in embryonic stem cells (Wang et al., 2008).
With the goal of delivering individual miRNAs to DGCR8-defi-
cient T cells, we first optimized the transfection of primary CD4+172 Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc.T cells by electroporation (Kim et al.,
2008). By using siRNA to silence YFP
expression in Dgcr8fl/fl Cd4-cre YFP+
cells, we were able to achieve transfec-tion efficiency of greater than 90% with minimal effects on cell
viability (data not shown). To observe changes in miRNA activity,
we generated retroviral sensor constructs containing fourmiRNA
binding sites downstream of a GFP coding region. As expected,
sensor GFP expression was repressed in miRNA-expressing
wild-type cells as compared to DGCR8-deficient cells (Fig-
ure S3A). We next used these sensors to validate miRNA gain
of function after transfection of primary T cells with synthetic
miRNA oligonucleotides. In DGCR8-deficient cells, GFP expres-
sion from a miR-29a sensor was repressed after transfection
with miR-29a but not miR-150 (Figure S3B). Similarly, a sensor
with miR-150 binding sites was repressed by miR-150 but not
miR-29a (Figure S3B). These results indicate that synthetic
miRNA oligonucleotides can be successfully introduced into
primary T cells with high efficiency and exhibit sequence-
specific repression of target genes, even in T cells that are
otherwise deficient in their ability to generate mature miRNAs.
We next sought to determine the appropriate set of miRNAs
for analysis in a functional screen. Small RNA libraries for
deep sequencing were generated from wild-type CD4+ T cells
activated in vitro for 44 hr, providing a relevant ‘‘snapshot’’ of
the miRNAs present near the time of miRNA introduction in
our screen (Figure 3A; Table S1). From these data we chose
Immunity
miR-29 Regulates Th1 Cell Differentiation110 miRNAs to screen for function in DGCR8-deficient helper
T cells. All miRNAs for which we obtained at least 100 reads
permillion total reads from two independent sequencing libraries
were included.
A schematic of the screening procedure is depicted in Fig-
ure 3B. Carboxyluorescein diacetate succinimidyl ester
(CFSE)-labeled DGCR8-deficient T cells were activated in vitro,
transfected with individual miRNAs after 24 hr, returned to
stimulus for an additional 40 hr, and then cultured in media
containing IL-2. Proliferation was measured by CFSE dilution
on the fourth day, and the remaining cells were transfected again
prior to cytokine analysis to overcome miRNA turnover and
dilution. The next day, cells were restimulated and stained intra-
cellularly for analysis of cytokine production.
miR-17 and miR-92 Family miRNAs Promote T Cell
Proliferation
An initial screen of our T cell miRNA library revealed several
miRNAs with a positive effect on proliferation (Figure 3C; Table
S2). Of the 10 miRNAs that most significantly increased prolifer-
ation, five (miR-17, miR-20a, miR-93, miR-106a, miR-106b)
belong to the miR-17 seed family and an additional three
(miR-25, miR-32, miR-92a) share the miR-92 seed sequence.
This represents three of four miR-25 seed family miRNAs
assayed and five of six miR-17 family miRNAs assayed (Fig-
ure 3D). These findings are consistent with the established role
for the miR-1792 cluster in regulating proliferation of multiple
cell types (Mendell, 2008), including its ability to induce lympho-
proliferative disease when overexpressed in mice (He et al.,
2005; Xiao et al., 2008). The other two miRNA seed families
that are represented in the miR-1792 cluster, miR-18 and
miR-19, did not promote proliferation in our screen.
To validate these results, we repeated proliferation assayswith
individual members of the miR-1792 cluster (Figure 3E). These
experiments verified thatmiR-17andmiR-92aboth increased the
proliferation index of DGCR8-deficient T cells approximately
10%, representing a partial but consistent rescue (p < 0.01
ANOVA, Tukey’s post hoc test). To address the mechanism of
this effect, we analyzed the expression of validated miR-1792
targets with established roles in cell proliferation and survival.
Previous reports have identified Pten as a target of miR-17 and
miR-19 (Olive et al., 2009; Xiao et al., 2008), Bim as a target of
miR-17 and miR-92 (Koralov et al., 2008; Olive et al., 2009;
Petrocca et al., 2008; Xiao et al., 2008), and p21 as a target of
the miR-17 seed family (Ivanovska et al., 2008; Petrocca et al.,
2008; Wang et al., 2008). However, these targets were not
affected by transfection with miR-17 or miR-92a, suggesting
that additional targetsmay be responsible for the proproliferative
effects of thesemiRNAs in helper T cells (Figure S4A). In addition,
miR-17 and miR-92a increased proliferation without observable
effects on cell survival, whereas miR-19 increased cell viability
relative to control transfected cells but did not augment prolifer-
ation (Figure S4B). Taken together, these results demonstrate
the effectiveness of this screening approach for identifying
specific functional capabilities of individual miRNAs.
miR-29a and miR-29b Regulate IFN-g Production
Building on our success in identifying miRNA functions that
are consistent with their known biological activities, we nextscreened for individual miRNAs that can rescue the aberrant
IFN-g production of DGCR8-deficient T cells. In this screen,
both miR-29a and miR-29b significantly decreased the
frequency of IFN-g-producing cells (Figure 4A; Table S2). The
only other member of this seed family, miR-29c, was not
included in our screen because of its low expression in helper
T cells (Figure S5). Additional transfection experiments con-
firmed the ability of both miR-29a and miR-29b to reduce IFN-g
production in DGCR8-deficient T cells (Figure 4B) and that this
effect was dose dependent (Figure 4C). miR-29 had no signifi-
cant effect on the total frequency of IL-4- or IL-2-producing cells
(Figure 4D), nor did it affect cell proliferation (Figure 4E) or
viability (Figure 4F). miR-29 also repressed IFN-g production in
wild-type cells, even in conditions that strongly promote Th1
cell differentiation (Figures 4G and 4H). Taken together, these
findings indicate that miR-29 mediates its effects through
specific regulation of the IFN-g production pathway rather than
through general effects on T cell activation, cytokine production,
or cell fitness.
Genome-wide Analysis Identifies T-bet and Eomes
as Direct Targets of miR-29
To identify miR-29 targets that contribute to IFN-g regulation,
we conducted microarray analyses of gene expression in both
miR-29 gain- and loss-of-function conditions. A microarray-
based approach to target identification is supported by recent
evidence that miRNA-mediated changes in mRNA and protein
expression are highly correlated (Guo et al., 2010) For gain-of-
function experiments, we transfected DGCR8-deficient cells
with synthetic miR-29b, and for loss-of-function experiments,
we transfected wild-type cells with combined miR-29a and
miR-29b antisense inhibitors. As a class, predicted miR-29
targets (Friedman et al., 2009) were clearly repressed subse-
quent to miR-29b transfection in DGCR8-deficient cells
(Figure 5A, left). Of the 115 predicted miR-29 targets whose
expression was markedly changed after miR-29 transfection
(FDR < 0.1), 111 were downregulated and only 4 exhibited
increased expression (Figure 5B; Table S3). Predicted targets
were also upregulated as a class after inhibition of miR-29 in
wild-type T cells (Figure 5A, right). Notably, the majority of
predicted miR-29 targets that were downregulated in response
to miR-29b in DGCR8-deficient cells were also upregulated in
wild-type cells transfected with miR-29 inhibitors (Figure 5B).
Taken together, these data indicate that many of these genes
not only are capable of responding to miR-29 overexpression
but are in fact subject to regulation by endogenous miR-29 in
wild-type T cells. Among the genes regulated in this manner,
we identified several previously validated targets of miR-29
including Dnmt3a, Dnmt3b, Cdk6, and Mcl1 (Figure 5C; Fabbri
et al., 2007; Garzon et al., 2009; Mott et al., 2007). Many genes
identified in this analysis probably contribute to the overall
function of miR-29 in helper T cells.
In regards to the regulation of IFN-g specifically, we were
intrigued that both Tbx21 (encoding T-bet) and Eomes appeared
to be regulated by miR-29. Both T-bet and Eomes have known
roles in IFN-g production and both contain highly conserved
30UTR miR-29 binding sites. We validated the microarray
findings for these genes by quantitiative polymerase chain
reaction (qPCR) and found a 50% reduction of Tbx21 mRNAImmunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc. 173
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Figure 4. miR-29a and miR-29b Rescue Aberrant IFN-g Production by miRNA-Deficient CD4+ T Cells and Repress IFN-g Production
by Wild-Type Th1 Cells
(A) Z scores for frequency of IFN-g production among restimulated DGCR8-deficient cells transfected with individual miRNAs as described in Figure 3B.
miRNAs with a proliferation score of Z <1.5 or Z > 1.5 were not included in the IFN-g analysis because of possible indirect effects of survival or proliferation on
cytokine production.
(B) Intracellular cytokine stains for IFN-g and IL-4 in transfected and restimulated DGCR8-deficient CD4+ T cells. Data are representative of three independent
experiments.
(C) Frequency of IFN-g production among Dgcr8fl/fl Cd4-cre CD4+ T cells transfected with increasing concentration of miR-29b. Data are representative of two
independent experiments; error bars represent range from two independent transfections.
(D) Summary of cytokine production by miR-29b-transfected and restimulated Dgcr8fl/fl Cd4-cre CD4+ T cells. Values are means ± SD from four biological
replicates in two independent experiments; ***p < 0.001; Student’s two-tailed t test.
(E) Proliferation analysis by CFSE dilution of transfected Dgcr8fl/fl Cd4-cre cells on day 5.
(F) Cell viability analysis of transfected Dgcr8fl/fl Cd4-cre cells on day 5. Numbers indicate percentage of total events that are viable.
(G and H) IFN-g production by restimulated, C57BL/6 CD4+ cells cultured in 100 pg/mL IL-12 or Th1 cell-type conditions and transfected with miR-29b or control
miRNA. Values in (H) represent mean ± SD from three independent transfections; data are representative of two independent experiments.
Immunity
miR-29 Regulates Th1 Cell Differentiationafter miR-29 transfection in miRNA-deficient cells and a 30%
increase after miR-29 inhibition in wild-type cells (Figure 5D).
Eomes mRNA was affected to an even greater extent, with174 Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc.expression reduced by 80% in miR-29-transfected DGCR8-
deficient cells and increased by 70% after miR-29 inhibition
in wild-type cells (Figure 5D).
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Figure 5. Genome-wide Analysis Identifies T-bet and Eomes as miR-29 Targets
(A) Cumulative distribution of mRNA expression changes frommicroarray data subsequent to transfection with miR-29b in Dgcr8fl/flCd4-cre CD4+ T cells (left) or
miR-29 inhibitor in C57BL/6 (wild-type) CD4+ T cells (right). Negative values indicate downregulation of mRNA after transfection. Black lines represent the entire
microarray gene set, gray lines represent the subset of genes that are Targetscan computationally predictedmiR-29 targets, and red lines represent the subset of
predicted targets with 8-mer binding sites perfectly complementary to the entire miR-29 seed sequence.
(B) Scatter plot of the change in mRNA expression after miR-29 transfection in Dgcr8fl/fl Cd4-cre cells (y axis) and change in expression after miR-29 inhibitor
transfection in wild-type cells (x axis). Each point represents a different gene array probe. Included are predicted miR-29 targets differentially expressed
(FDR < 0.1) after miR-29 transfection.
(C) Heatmap representation of changes in gene expression after transfection for three independent biological samples of each genotype. Scale is log2 fold
change in array hybridization intensity compared to control transfected cells.
(D) qPCR validation of array data for miR-29 candidate targets of interest. mRNA expression was normalized to Gapdh and is relative to expression in control
transfected cells. Values are means ± SD from three biological replicates.
(E and F) Primary Dgcr8fl/fl Cd4-cre (E) or wild-type (F) CD4+ T cells were cotransfected with a dual luciferase reporter and miR-29b or control miRNA (E); miR-29
inhibitors or control inhibitor (F). Luciferase reporters contained the full-length mouse 30UTR of Tbx21 or Eomes. Renilla luciferase activity was measured 24 hr
after transfection and normalized to firefly luciferase activity. Values are relative to normalized luciferase in control transfected cells. Data are representative of
three independent experiments and values are means ± SD from three independent transfections.
*p < 0.05, **p < 0.01; ANOVA Tukey’s post hoc test.
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miR-29 Regulates Th1 Cell DifferentiationTo determine whether T-bet and Eomes are in fact direct
targets of miR-29, we transfected primary T cells with dual lucif-
erase reporters containing the full-lengthmouse Tbx21 or Eomes
30UTR. In DGCR8-deficient T cells, miR-29b reduced expression
of the cotransfected Tbx21 30UTR reporter by approximately65% and miR-29b reduced expression of the Eomes 30UTR
reporter by 80% (Figure 5E). In wild-type T cells, miR-29 inhibi-
tion significantly ‘‘derepressed’’ the full-length Tbx21 30UTR
and Eomes 30UTR reporters by 20% and 40%, respectively (Fig-
ure 5F). These results demonstrate that both the Tbx21 andImmunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc. 175
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Figure 6. miR-29 Regulates T-box Tran-
scription Factor Protein Expression In Vitro
and In Vivo
(A and B) CD4+ cells from Dgcr8fl/fl Cd4-cre mice
or Dgcr8+/fl Cd4-cre mice were cultured in ThN
conditions and stained intracellularly for T-bet
and Eomes protein 24 hr after transfection. T-bet
data are on day 2 and Eomes data are on day 5.
Values are means ± SD from three independent
transfections; **p < 0.01; ANOVA Tukey’s post
hoc test.
(C) MFI of intracellular T-bet stains for Thy1.1+
CD45.1+ cells subsequent to adoptive transfer of
CD4+ SMARTA T cells and LCMV infection.
Transferred and transduced cells were identified
by congenic CD45.1 and retroviral Thy1.1 ex-
pression, respectively.
(D) MFI of intracellular IFN-g for transduced and
transferred CD4+ SMARTA T cells (as in C). Cells
were stimulated with 1 mM gp61-80 peptide. Data
represent IFN-g MFI for TNF-a-producing cells.
(E) MFI of intracellular T-bet in CD8+ P14 T cells
after LCMV infection, analyzed as in (C).
(F) Transduced CD8+ P14 T cells (as in E) were
analyzed for KLRG1 and IL-7Ra expression.
Values are mean frequency (%) ± SD; n = 3;
p < 0.05 for both populations; Student’s two-tailed
t test.
Data in (C)–(F) are representative of two indepen-
dent experiments; **p < 0.01; Student’s two-tailed
t test.
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miR-29 Regulates Th1 Cell DifferentiationEomes 30UTRs are directly responsive to miR-29 and that
physiological expression of miR-29 in wild-type helper T cells
is sufficient to mediate these effects.
miR-29 Regulates T-box Transcription Factor Protein
Expression In Vitro and In Vivo
Intracellular staining confirmed that miR-29 returned the
elevated T-bet protein expression of miRNA-deficient cells to
an amount near that of wild-type cells (Figure 6A). Although
Eomes expression is typically very low in CD4+ T cells, Eomes
was also elevated in miRNA-deficient CD4+ cells and miR-29
transfection rescued this aberrant expression (Figure 6B).176 Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc.To analyze miR-29 function in helper
T cells in vivo, we retrovirally transduced
SMARTA CD4+ T cell receptor (TCR)
transgenic T cells with either pri-miR-
29a or control pri-miR-1. Transduced
cells were adoptively transferred and
recipientmicewere infectedwith lympho-
cytic choriomeningitis virus (LCMV). On
day 8 posttransfer, we analyzed T-bet
and Eomes expression in transduced
cells. As expected of wild-type CD4+
T cells, Eomes expression was negligible
regardless of miR-29 overexpression
(data not shown). However, T-bet ex-
pression was significantly reduced in
the miR-29-transduced cells (Figure 6C).
We also observed significantly decreasedIFN-g production by miR-29-overexpressing cells, as indicated
by decreased mean fluorescence intensity (MFI) among CD4+
effector T cells producing both IFN-g and tumor necrosis
factor-a (TNF-a) (Figure 6D).
To further assess the in vivo role of T-bet regulation bymiR-29,
we conducted additional experiments with P14 LCMV-specific
TCR transgenic CD8+ T cells. Again we observed a decrease in
T-bet in miR-29-overexpressing cells (Figure 6E). Furthermore,
we analyzed surface expression of Killer cell lectin-like G1
(KLRG1) and the IL-7 receptor alpha-chain (IL-7Ra) as markers
of CD8+ effector cell subsets. In miR-29-overexpressing cells,
we observed fewer KLRG1+IL-7Ra cells and an increased
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Figure 7. miR-29-Mediated Repression of IFN-g
Involves Regulation of Both T-bet and Eomes
Dgcr8fl/fl Cd4-cre CD4+ T cells were transfected with
control miRNA, miR-29b, siRNA targeting T-bet (siTbet),
and/or siRNA targeting Eomes (siEomes). Cells were
cultured in ThN conditions and transfected at 24 hr and
96 hr. T-bet (A), Eomes (B), and IFN-g (C) protein
expression was analyzed subsequent to restimulation at
120 hr. Values are means ± SD from three independent
transfections; ***p < 0.001, *p < 0.05; ANOVA Tukey’s post
hoc test.
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miR-29 Regulates Th1 Cell Differentiationfrequency of KLRG1IL-7Ra+ cells (Figure 6F). These results are
consistent with reports that KLRG1+IL-7Ra short-lived effector
cells (SLECs) are particularly sensitive to graded expression of
T-bet (Joshi et al., 2007). Taken together, these results demon-
strate the ability of miR-29 to functionally contribute to T-bet
regulation in both CD4+ and CD8+ T cells in vivo.
Regulation of IFN-g by miR-29 Involves Both T-bet
and Eomes
To measure the functional relevance of T-bet and Eomes as
miR-29 targets, we determined whether direct T-bet and Eomes
silencing with siRNA would phenocopy miR-29 gain of function
in DGCR8-deficient T cells. T-bet siRNA reduced T-bet expres-
sion to an even greater extent than miR-29 (Figure 7A) and did
lead to a significant reduction in IFN-g production (Figure 7C).
Surprisingly, however, T-bet reduction alone was not sufficient
to reduce IFN-g production to the same extent achieved by
miR-29b (Figure 7C). Direct silencing of Eomes alone had no
effect on IFN-g production (Figures 7B and 7C), probably
because of a dominant effect of T-bet on IFN-g production in
these cells. However, combined silencing of both T-bet and
Eomes reduced IFN-g production to a greater extent than
T-bet siRNA alone (Figure 7C). Thus, T-bet expression doesImmunity 35, 1influence IFN-g production and miR-29 does
repress T-bet, but T-bet repression alone
cannot fully account for the ability of miR-29 to
regulate IFN-g. Although we must acknowledge
that additional miR-29 targets may also
contribute, we conclude that miR-29 regulates
IFN-g production by simultaneously targeting
T-bet and Eomes, two proteins with overlapping
transcriptional activity.
DISCUSSION
We and others have previously shown that
miRNA-deficient helper T cells exhibit defects
in proliferation and the regulation of cytokine
production. However, defining the contributions
of specificmiRNAs to these processes has been
challenging because of cooperation and redun-
dancy among miRNAs. In this study, we utilized
T cells from Dgcr8fl/fl Cd4-cre mice as a source
of miRNA-deficient cells into which individual
miRNAs could be reintroduced and assayed
for their ability to rescue phenotypes associatedwith miRNA deficiency. Optimization of primary T cell transfec-
tion allowed an efficient functional screen of more than 100
miRNAs in primary T cells. Starting with this screen, we identified
individual miRNAs that rescue the defects of miRNA-deficient
T cells and further determined the molecular mechanism of this
activity. miR-17 and miR-92 family members supported prolifer-
ation of DGCR8-deficient T cells, whereas miR-29 family
members potently and specifically inhibited IFN-g production.
miR-29 directly targeted T-bet and its close relative Eomes.
Both endogenous and overexpressed miR-29 inhibited the
expression of these key transcriptional regulators of IFN-g
expression. This coordinated repression of functional homologs
by a single miRNA represents an intriguing mode of cell fate
regulation and may apply broadly to miRNA function in other
settings.
Introduction of miRNAs into otherwise miRNA-deficient cells
proved to be an especially sensitive system for detecting bona
fide functional effects. However, we also considered the possi-
bility that a screen of all known miRNAs could reveal ‘‘artificial’’
functions for miRNAs not normally expressed at meaningful
concentrations. For this reason, we limited our screen tomiRNAs
expressed in activated CD4+ T cells. Further analysis of the
regulation of miRNA expression during T cell differentiation69–181, August 26, 2011 ª2011 Elsevier Inc. 177
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and analyzing functional effects and target genes in wild-type
T cells.
Multiple members of the miR-17 and miR-92 miRNA families
were able to promote proliferation of DGCR8-deficient helper
T cells. All three clusters containing thesemiRNAs are expressed
in helper T cells, and two of them (miR-1792 and miR-
106a363) are strongly induced upon T cell activation (Barski
et al., 2009; Kuchen et al., 2010). Overexpression of the entire
miR-1792 cluster promotes lymphomagenesis in B cells and
can substitute for costimulation to promote helper T cell prolifer-
ation (He et al., 2005; Xiao et al., 2008). Our screening system
allowed us to dissect the functional contribution of individual
miRNAs within these clusters. miR-17 and miR-92 family
members were key players in regulating the rapid proliferation
of activated T cells. Of note, miRNAs with the miR-17 seed
sequence also promote cell cycle progression in embryonic
stem cells and human cell lines (Ivanovska et al., 2008; Petrocca
et al., 2008;Wang et al., 2008). Clarifying the regulatory networks
that enable miR-1792 miRNAs to cooperatively regulate cell
proliferation and survival will be important to fully understand
their role in immunity and immune dysfunction.
miRNA effects on cell proliferation and survival appear to be
nearly universal in diverse somatic cell types. In contrast,
the increased propensity of both Dicer- and DGCR8-deficient
helper T cells to produce IFN-g reveals a noteworthy case of a
cell type-specific immune function that is regulated by the
miRNA pathway. Our findings demonstrate that miR-29 is an
important regulator of the IFN-g pathway in helper T cells and
that this regulation is mediated in part through the Th1 cell tran-
scription factor T-bet. T-bet heterozygous mice, which exhibit
only a 50% reduction in T-bet protein, spontaneously develop
Th2 cell-mediated airway inflammation (Finotto et al., 2002).
Thus, even moderate repression of T-bet by miR-29 may have
important physiological implications. Consistent with the well-
established role of T-bet in promoting IFN-g production,
siRNA-mediated reduction of T-bet did repress IFN-g in our
experiments. Surprisingly, however, miR-29 had a far more
potent effect than T-bet reduction alone. These findings indicate
that the effects of miR-29 on IFN-g are mediated through both
T-bet and additional targets and support the notion that miRNAs
rarely function through repression of a single target gene.
Microarray analysis after miR-29 gain of function and loss of
function demonstrated that many genes with canonical miR-29
binding sites are markedly repressed by both overexpressed
and endogenous miR-29. These data confirm previously vali-
dated targets of miR-29 and identify many additional candidate
targets. At least one previously validated target, Dnmt3a, has
been implicated in the regulation of cytokine production (Gam-
per et al., 2009) and may also be involved in the observed func-
tion of miR-29 reported here. Of particular interest to this study
was Eomes, which encodes a T-box transcription factor closely
related to T-bet. Although Eomes is known to be important for
IFN-g production in CD8+ T cells, it is normally expressed at
very low amounts in CD4+ effector cells. However, ectopic
expression of Eomes can promote IFN-g production in CD4+
cells and mechanisms for the transcriptional repression of
Eomes in CD4+ cells have been described (Pearce et al., 2003;
Suto et al., 2006; Yagi et al., 2010). These findings underscore178 Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc.the importance ofmaintaining Eomes silencing for proper control
of helper T cell differentiation and cytokine production. Conceiv-
ably, even transient or minimal expression of Eomes could
initiate the IFN-g and T-bet positive feedback loop that drives
Th1 cell differentiation. We found that miRNA-deficient CD4+
cells did not appropriately restrict T-bet or Eomes, and RNAi
experiments showed that both contributed to aberrant IFN-g
production. The direct targeting of both T-bet and Eomes by
miR-29 implicates a central role for this miRNA in the phenotype
of miRNA-deficient CD4+ T cells. However, additional miRNAs
probably contribute as well, perhaps through effects on tran-
scription factors suchasGATA3andRunx3 that canalso regulate
Eomesand IFN-gexpression (Yagi et al., 2010). Ifng itself hasalso
been described as a computationally predicted target of miR-29
(Betel et al., 2008). However, we could not confirm any effect of
miR-29 on a full-length Ifng 30UTR reporter in primary T cells,
perhaps because of the dominant miRNA-independent regula-
tion of the Ifng 30UTR in helper T cells (Villarino et al., 2011).
Taken together, our data suggest that miR-29 may have
evolved as an important regulator of CD4+ effector T cell cyto-
kine production, both by modulating expression of the lineage-
specific transcription factor T-bet and by restricting leaky tran-
scription of the functionally overlapping T-box transcription
factor Eomes. CD4+ T cells are distinguished by their ability to
undergo functional polarization into diverse effector subsets,
some of which depend on silencing of Ifng for proper immune
function. Therefore, CD4+ T cells must have mechanisms avail-
able for robust regulation of both T-bet and Eomes. In contrast,
miRNA-deficient NK cells and CD8+ T cells do not exhibit
increased IFN-g production as CD4+ T cells do (Bezman et al.,
2010; Zhang and Bevan, 2010). However, because activated
NK andCD8+ T cells express T-bet and Eomes, miR-29 probably
regulates their expression in these cells as well. Indeed, we
observed decreased T-bet in CD8+ T cells overexpressing
miR-29, and this corresponded with a significant decrease in
the T-bet-dependent SLEC population during an in vivo immune
response to LCMV.
Current models of helper T cell differentiation emphasize the
role of cytokine and transcription factor positive feedback loops
that polarize gene expression patterns. This feature makes T cell
fate decisions very sensitive to small changes in the expression
of key genes in the regulatory circuit and therefore especially
amenable to regulation by miRNAs. Indeed, multiple molecular
players in the Th1 cell pathway have now been characterized
as targets of miRNAs. In addition to the current findings
regarding miR-29, miR-155 and miR-146 have been shown to
target Ifngr1 and Stat1, respectively, and miR-155-deficient
T cells display dysregulated Th2 cell differentiation (Banerjee
et al., 2010; Lu et al., 2010; Rodriguez et al., 2007; Thai et al.,
2007). We did not observe increased IFNGR1 expression in
DGCR8-deficient T cells, and miR-155 was excluded from
our primary cytokine screen because it also compromised
T cell proliferation. STAT1 was increased in DGCR8-deficient
cells, and miR-146 transfection 24 hr after T cell activation
consistently but modestly repressed IFN-g production. It is
possible that even earlier introduction of miR-146 would have
had a larger effect on IFN-g production. To this extent, naive
DGCR8-deficient T cells exhibited increased phosphorylated
STAT1 in response to IFN-g as compared to wild-type cells.
Immunity
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to the time when miRNAs were reintroduced into T cells in this
study. Thus, our screen may underestimate the role of miR-146
and other miRNAs whose targets may be most critical for very
early events in T cell activation and differentiation.
In conclusion, we have identified individual miRNAs that have
significant effects on proliferation and cytokine production by
helper T cells. These processes are central to appropriate
immune system function and their dysregulation can have
important pathological consequences. As such, miR-29 regula-
tion of IFN-g production and helper T cell differentiation has
important implications for human diseases that are associated
with T cell-mediated immunity such as asthma, type 1 diabetes,
and multiple sclerosis. Understanding the complete set of
functions for miR-29 and other miRNAs in helper T cells will
probably provide useful insights for the development of novel
immune therapies. Such therapies may focus on the miRNAs
themselves or may modulate pathways implicated through
characterization of miRNA target genes. Our results broaden
our understanding of genome regulation by miR-29 and may
have implications for other biological and disease processes
that have also been linked to miR-29 function including fibrosis,
HIV latency, and leukemia (Croce, 2009; Nathans et al., 2009;
van Rooij et al., 2008).
EXPERIMENTAL PROCEDURES
Mice
Dgcr8fl/fl and Gt(ROSA)26Sortm1Hjf (R26-tdRFP) have been described
previously (Luche et al., 2007; Wang et al., 2007). C57BL/6 (NCI), Cd4-cre
(Taconic), Gt(ROSA)26Sortm1(EYFP)Cos (R26-YFP), SMARTA, and P14 mice
(Jax) were purchased. All mice were housed and bred in specific-
pathogen-free conditions in the Animal Barrier Facility at the University of
California, San Francisco. All animal experiments were approved by the
Institutional Animal Care and Use Committee of the University of California,
San Francisco.
T Cell Stimulation and Transfection
CD4+ T cells from spleen and lymph nodes of young mice (4–7 weeks old)
were isolated by magnetic bead selection (Dynal), stimulated with anti-CD3
and anti-CD28, and cultured in polarizing conditions as indicated. Cells
were transfected by the Neon electroporation transfection system (Invitrogen)
with an optimized version of the manufacturers’ recommended protocol.
miRIDIAN miRNA mimics, inhibitors, controls, and T-bet siRNA were from
Dharmacon. Eomes siRNA was from QIAGEN. See Supplemental Information
for details.
miRNA Screening and Analysis
Cells were stimulated at 1 3 106 cells/mL for 24 hr in 6-well plates. Cells
were pooled and 0.2 3 106 cells were transfected with an individual miRNA.
After transfection, cells were placed in goat anti-hamster IgG-coated wells
of a 24-well plate in 0.5 ml media with anti-CD3 and anti-CD28. Availability
of mice and cells allowed 16–24 miRNAs to be screened at one time
such that the complete screen of all miRNAs consisted of five batches.
CFSE analysis on day 4 was used to calculate a proliferation index. Prolifera-
tion index is the average number of cell divisions among cells that underwent
at least one division (Flowjo analysis software). 0.23 106 cells of the remaining
cells from each well were transfected again on day 4 and restimulated for
intracellular staining on day 5. For each batch, the proliferation index and
the frequency of IFN-g-producing cells was normalized to the batch median
to give a proliferation score and IFN-g score, respectively. These values
were then used to generate Z scores for the entire set of miRNAs screened
(Z = x-mean/SD, where x is the proliferation score or IFN-g score for each
individual miRNA).Adoptive Transfer and LCMV Infection
CD4+ T cells from SMARTA mice (CD45.1) were isolated by magenetic bead
selection, activated in vitro as described, and transduced with pri-miR
retroviral vectors (pri-miR-29a or pri-miR-1) at 40 hr. At 45 hr cells were
washed and resuspended in PBS, and 5 3 104 cells were injected intrave-
nously into recipient CD45.2 C57BL/6 mice (NCI). One day later, mice were
infected intraperitoneally with 2 3 105 plaque forming units of LCMV. On day
8 posttransfer, total splenocytes were harvested and immediately fixed for
analysis. CD8+ T cells were activated in vivo, transduced, and transferred
as described (Hu et al., 2011) and splenocytes were analyzed on day 7
posttransfer.
Microarray Procedures and Analysis
Sample preparation, labeling, array hybridizations, and false discovery rate
calculations were performed according to standard protocols of the UCSF
Shared Microarray Core Facilities (http://www.arrays.ucsf.edu) and Agilent
(http://www.agilent.com) as previously described (Price et al., 2010).
Luciferase Reporter Assays
The full-length 30UTR of Tbx21 and Eomes were cloned into the psiCHECK-2
luciferase reporter construct (Promega). CD4+ T cells were cotransfected on
day 4 of culture with reporter constructs andmiRNAmimics or inhibitors. Lucif-
erase activity was measured 24 hr after transfection with the Dual Luciferase
Reporter Assay System (Promega) and a FLUOstar Optima plate-reader
(BMG Labtech).
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database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE30525.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
doi:10.1016/j.immuni.2011.07.009.
ACKNOWLEDGMENTS
The authors thank S. Abdul-Wajid and M. Panduro-Sicheva for technical
assistance; H.J. Fehling (Institute for Immunology, University Clinics Ulm)
for providing R26-tdRFP reporter mice; R. Barbeau, J. Pollack, A. Barczak,
and D. Erle for advice and expert assistance with microarray experiments;
O. Solberg and P. Woodruff for help with bioinformatic analysis; E. Fink for
advice on the use of statistics; A. Weiss and L. Jeker for critical reading of
the manuscript; and members of the UCSF miRNA in lymphocytes interest
group for helpful discussions. This work was supported by the Dana Founda-
tion, the Burroughs Wellcome Fund (CABS 1006173), the UCSF Program for
Breakthrough Biomedical Research, the UCSF/NIH Medical Scientist Training
Program (D.F.S. and M.F.T.), and the Susan G. Komen Foundation.
Received: February 8, 2011
Revised: May 24, 2011
Accepted: July 15, 2011
Published online: August 4, 2011
REFERENCES
Afkarian, M., Sedy, J.R., Yang, J., Jacobson, N.G., Cereb, N., Yang, S.Y.,
Murphy, T.L., and Murphy, K.M. (2002). T-bet is a STAT1-induced regulator
of IL-12R expression in naı¨ve CD4+ T cells. Nat. Immunol. 3, 549–557.
Ansel, K.M., Djuretic, I., Tanasa, B., and Rao, A. (2006). Regulation of Th2
differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24, 607–656.
Babiarz, J.E., Ruby, J.G.,Wang, Y., Bartel, D.P., andBlelloch, R. (2008).Mouse
ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-
independent, Dicer-dependent small RNAs. Genes Dev. 22, 2773–2785.Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc. 179
Immunity
miR-29 Regulates Th1 Cell DifferentiationBanerjee, A., Schambach, F., DeJong, C.S., Hammond, S.M., and Reiner, S.L.
(2010). Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur. J.
Immunol. 40, 225–231.
Barski, A., Jothi, R., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., and
Zhao, K. (2009). Chromatin poises miRNA- and protein-coding genes for
expression. Genome Res. 19, 1742–1751.
Bartel, D.P. (2009). MicroRNAs: target recognition and regulatory functions.
Cell 136, 215–233.
Betel, D., Wilson, M., Gabow, A., Marks, D.S., and Sander, C. (2008). The
microRNA.org resource: targets and expression. Nucleic Acids Res. 36
(Database issue), D149–D153.
Bezman, N.A., Cedars, E., Steiner, D.F., Blelloch, R., Hesslein, D.G., and
Lanier, L.L. (2010). Distinct requirements of microRNAs in NK cell activation,
survival, and function. J. Immunol. 185, 3835–3846.
Chong, M.M., Rasmussen, J.P., Rudensky, A.Y., and Littman, D.R. (2008). The
RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory
disease. J. Exp. Med. 205, 2005–2017.
Cobb, B.S., Hertweck, A., Smith, J., O’Connor, E., Graf, D., Cook, T., Smale,
S.T., Sakaguchi, S., Livesey, F.J., Fisher, A.G., and Merkenschlager, M.
(2006). A role for Dicer in immune regulation. J. Exp. Med. 203, 2519–2527.
Croce, C.M. (2009). Causes and consequences of microRNA dysregulation in
cancer. Nat. Rev. Genet. 10, 704–714.
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S.,
Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007). MicroRNA-29
family reverts aberrant methylation in lung cancer by targeting DNA methyl-
transferases 3A and 3B. Proc. Natl. Acad. Sci. USA 104, 15805–15810.
Finotto, S., Neurath, M.F., Glickman, J.N., Qin, S., Lehr, H.A., Green, F.H.,
Ackerman, K., Haley, K., Galle, P.R., Szabo, S.J., et al. (2002). Development
of spontaneous airway changes consistent with human asthma in mice lacking
T-bet. Science 295, 336–338.
Friedman, R.C., Farh, K.K., Burge, C.B., andBartel, D.P. (2009). Mostmamma-
lian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92–105.
Gamper, C.J., Agoston, A.T., Nelson, W.G., and Powell, J.D. (2009).
Identification of DNA methyltransferase 3a as a T cell receptor-induced
regulator of Th1 and Th2 differentiation. J. Immunol. 183, 2267–2276.
Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C.E., Callegari, E., Schwind, S.,
Pang, J., Yu, J., Muthusamy, N., et al. (2009). MicroRNA-29b induces global
DNA hypomethylation and tumor suppressor gene reexpression in acute
myeloid leukemia by targeting directly DNMT3A and 3B and indirectly
DNMT1. Blood 113, 6411–6418.
Guo, H., Ingolia, N.T., Weissman, J.S., and Bartel, D.P. (2010). Mammalian
microRNAs predominantly act to decrease target mRNA levels. Nature 466,
835–840.
He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D.,
Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J., and
Hammond, S.M. (2005). A microRNA polycistron as a potential human
oncogene. Nature 435, 828–833.
Hu, J.K., Kagari, T., Clingan, J.M., and Matloubian, M. (2011). Expression
of chemokine receptor CXCR3 on T cells affects the balance between
effector and memory CD8 T-cell generation. Proc. Natl. Acad. Sci. USA 108,
E118–E127.
Ivanovska, I., Ball, A.S., Diaz, R.L., Magnus, J.F., Kibukawa, M., Schelter, J.M.,
Kobayashi, S.V., Lim, L., Burchard, J., Jackson, A.L., et al. (2008). MicroRNAs
in the miR-106b family regulate p21/CDKN1A and promote cell cycle progres-
sion. Mol. Cell. Biol. 28, 2167–2174.
Joshi, N.S., Cui, W., Chandele, A., Lee, H.K., Urso, D.R., Hagman, J., Gapin, L.,
and Kaech, S.M. (2007). Inflammation directs memory precursor and short-
lived effector CD8(+) T cell fates via the graded expression of T-bet transcrip-
tion factor. Immunity 27, 281–295.
Kim, J.A., Cho, K., Shin, M.S., Lee, W.G., Jung, N., Chung, C., and Chang, J.K.
(2008). A novel electroporation method using a capillary and wire-type
electrode. Biosens. Bioelectron. 23, 1353–1360.
Koralov,S.B.,Muljo,S.A.,Galler,G.R.,Krek,A.,Chakraborty, T., Kanellopoulou,
C., Jensen,K.,Cobb,B.S.,Merkenschlager,M.,Rajewsky,N., andRajewsky,K.180 Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc.(2008).Dicer ablationaffects antibodydiversity andcell survival in theB lympho-
cyte lineage. Cell 132, 860–874.
Kuchen, S., Resch, W., Yamane, A., Kuo, N., Li, Z., Chakraborty, T., Wei, L.,
Laurence, A., Yasuda, T., Peng, S., et al. (2010). Regulation of microRNA
expression and abundance during lymphopoiesis. Immunity 32, 828–839.
Lighvani, A.A., Frucht, D.M., Jankovic, D., Yamane, H., Aliberti, J., Hissong,
B.D., Nguyen, B.V., Gadina, M., Sher, A., Paul, W.E., and O’Shea, J.J.
(2001). T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid
cells. Proc. Natl. Acad. Sci. USA 98, 15137–15142.
Liston, A., Lu, L.F., O’Carroll, D., Tarakhovsky, A., and Rudensky, A.Y. (2008).
Dicer-dependent microRNA pathway safeguards regulatory T cell function.
J. Exp. Med. 205, 1993–2004.
Lu, L.F., Boldin, M.P., Chaudhry, A., Lin, L.L., Taganov, K.D., Hanada, T.,
Yoshimura, A., Baltimore, D., and Rudensky, A.Y. (2010). Function of
miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell
142, 914–929.
Luche, H., Weber, O., Nageswara Rao, T., Blum, C., and Fehling, H.J. (2007).
Faithful activation of an extra-bright red fluorescent protein in ‘‘knock-in’’
Cre-reporter mice ideally suited for lineage tracing studies. Eur. J. Immunol.
37, 43–53.
Mendell, J.T. (2008). miRiad roles for the miR-17-92 cluster in development
and disease. Cell 133, 217–222.
Mott, J.L., Kobayashi, S., Bronk, S.F., and Gores, G.J. (2007). mir-29 regulates
Mcl-1 protein expression and apoptosis. Oncogene 26, 6133–6140.
Muljo, S.A., Ansel, K.M., Kanellopoulou, C., Livingston, D.M., Rao, A., and
Rajewsky, K. (2005). Aberrant T cell differentiation in the absence of Dicer.
J. Exp. Med. 202, 261–269.
Nathans, R., Chu, C.Y., Serquina, A.K., Lu, C.C., Cao, H., and Rana, T.M.
(2009). Cellular microRNA and P bodies modulate host-HIV-1 interactions.
Mol. Cell 34, 696–709.
O’Connell, R.M., Rao, D.S., Chaudhuri, A.A., and Baltimore, D. (2010).
Physiological and pathological roles for microRNAs in the immune system.
Nat. Rev. Immunol. 10, 111–122.
Olive, V., Bennett, M.J., Walker, J.C., Ma, C., Jiang, I., Cordon-Cardo, C., Li,
Q.J., Lowe, S.W., Hannon, G.J., and He, L. (2009). miR-19 is a key oncogenic
component of mir-17-92. Genes Dev. 23, 2839–2849.
Pearce, E.L., Mullen, A.C., Martins, G.A., Krawczyk, C.M., Hutchins, A.S.,
Zediak, V.P., Banica, M., DiCioccio, C.B., Gross, D.A., Mao, C.A., et al.
(2003). Control of effector CD8+ T cell function by the transcription factor
Eomesodermin. Science 302, 1041–1043.
Petrocca, F., Visone, R., Onelli, M.R., Shah, M.H., Nicoloso, M.S., de Martino,
I., Iliopoulos, D., Pilozzi, E., Liu, C.G., Negrini, M., et al. (2008). E2F1-regulated
microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in
gastric cancer. Cancer Cell 13, 272–286.
Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J.,
and Locksley, R.M. (2010). Systemically dispersed innate IL-13-expressing
cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489–11494.
Rodriguez, A., Vigorito, E., Clare, S., Warren, M.V., Couttet, P., Soond, D.R.,
van Dongen, S., Grocock, R.J., Das, P.P., Miska, E.A., et al. (2007).
Requirement of bic/microRNA-155 for normal immune function. Science
316, 608–611.
Suto, A., Wurster, A.L., Reiner, S.L., and Grusby, M.J. (2006). IL-21 inhibits
IFN-gamma production in developing Th1 cells through the repression of
Eomesodermin expression. J. Immunol. 177, 3721–3727.
Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., and Glimcher,
L.H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commit-
ment. Cell 100, 655–669.
Szabo, S.J., Sullivan, B.M., Peng, S.L., and Glimcher, L.H. (2003). Molecular
mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21,
713–758.
Thai, T.H., Calado, D.P., Casola, S., Ansel, K.M., Xiao, C., Xue, Y., Murphy, A.,
Frendewey, D., Valenzuela, D., Kutok, J.L., et al. (2007). Regulation of the
germinal center response by microRNA-155. Science 316, 604–608.
Immunity
miR-29 Regulates Th1 Cell Differentiationvan Rooij, E., Sutherland, L.B., Thatcher, J.E., DiMaio, J.M., Naseem, R.H.,
Marshall, W.S., Hill, J.A., and Olson, E.N. (2008). Dysregulation of
microRNAs after myocardial infarction reveals a role of miR-29 in cardiac
fibrosis. Proc. Natl. Acad. Sci. USA 105, 13027–13032.
Villarino, A.V., Katzman, S.D., Gallo, E., Miller, O., Jiang, S., McManus, M.T.,
and Abbas, A.K. (2011). Posttranscriptional silencing of effector cytokine
mRNA underlies the anergic phenotype of self-reactive T cells. Immunity 34,
50–60.
Wang, Y., Medvid, R.,Melton, C., Jaenisch, R., and Blelloch, R. (2007). DGCR8
is essential for microRNA biogenesis and silencing of embryonic stem cell
self-renewal. Nat. Genet. 39, 380–385.
Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J.E., Baehner, L., and Blelloch,
R. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S
transition and promote rapid proliferation. Nat. Genet. 40, 1478–1483.Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J.,
Henderson, J.M., Kutok, J.L., and Rajewsky, K. (2008). Lymphoproliferative
disease and autoimmunity in mice with increased miR-17-92 expression in
lymphocytes. Nat. Immunol. 9, 405–414.
Yagi, R., Junttila, I.S., Wei, G., Urban, J.F., Jr., Zhao, K., Paul, W.E., and Zhu, J.
(2010). The transcription factor GATA3 actively represses RUNX3 protein-
regulated production of interferon-gamma. Immunity 32, 507–517.
Zhang, N., and Bevan, M.J. (2010). Dicer controls CD8+ T-cell activation,
migration, and survival. Proc. Natl. Acad. Sci. USA 107, 21629–21634.
Zhou, X., Jeker, L.T., Fife, B.T., Zhu, S., Anderson, M.S., McManus, M.T., and
Bluestone, J.A. (2008). Selective miRNA disruption in T reg cells leads to
uncontrolled autoimmunity. J. Exp. Med. 205, 1983–1991.
Zhu, J., Yamane, H., and Paul, W.E. (2010). Differentiation of effector CD4
T cell populations. Annu. Rev. Immunol. 28, 445–489.Immunity 35, 169–181, August 26, 2011 ª2011 Elsevier Inc. 181
